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ArcHimedes: A LArge scALe simuLAtion system for HeALtH cAre 
reseArcH And its APPLicAtions for AsiAn countries
Dinh T.
Evidera, San Francisco, CA, USA
The Archimedes Model is a carefully validated, clinically realistic, simulation model 
of diseases and health care. By using advanced methods of mathematics, comput-
ing, and data systems, the Model enables researchers and decision makers to make 
better informed decisions. The Archimedes Model includes a wide range of diseases/
conditions (diabetes, cardiovascular diseases, COPD, obesity, cancers) and detailed 
descriptions of health care delivery systems, interventions, tests, and treatments 
and patient and physician behaviors. The Model has been used by many organiza-
tions (e. g. goverments, pharmaceutical companies, insurance companies, disease 
organziations) accross the globe to help answer a wide variety of questions related to 
clinical trials, policy setting, performance measurement, and health economics and 
outcomes research. The Model has been adapted to a wide range of settings includ-
ing US, UK, France, Italy, Sweden, Norway, Poland, Japan, Brazil, and California. We 
will highlight a number of projects that were supported by EU and Japan, in which 
the Model was used to guide decision making around management of diabetes. We 
will also discuss the potential applications of adapting the Archimedes Model to 
other Asian countries (e. g. India or China) beyond Japan.
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‘serious iLLness insurAnce’ in cHinA: imPAct of noveL PubLic-PrivAte 
PAyment modeLs on Access to HeALtH cAre And drugs
Li X.1, Wang Y.2, Saraf S.3, Sherwin G.3, Akpinar P.3
1ICON Commercialisation & Outcomes, London, UK, 2National Social Security Institute, Ministry 
of Human Resources and Social Security of P.R.C, Beijing, China, 3ICON Pricing and Market Access, 
London, UK
Objectives: In mainland China, a large gap in the funding of catastrophic illnesses 
has existed for the past decade. In 2012, ‘serious illness insurance’ was proposed 
by the Government that involves using a portion of funds from the public insur-
ance and additional financial support from the government to cover major illnesses. 
Commercial health insurers collaborate with local authorities to provide this cover-
age through various models in different cities and regions. This research seeks to 
understand current models in different regions and to evaluate the implications for 
health care coverage and access to drugs. MethOdOlOgy: We conducted extensive 
literature review to understand the current landscape of the serious illness insurance. 
Primary research with a mix of stakeholders including private health insurers and 
regulatory authorities was also conducted in different provinces/ cities to further 
evaluate the regulatory framework, disease-specific coverage, funding pathways and 
implications for access to drugs. Results: Numerous models that vary with regards 
to design, funding and implementation are being piloted across provinces/ cities. Our 
research findings suggested that limited experience of the private insurers and uncer-
tainty around profitability places significant challenges on the future development 
of ‘serious illness insurance’. However, implementation of these insurance schemes 
has positively impacted health care coverage and access to drugs. cOnclusiOns: 
Our results demonstrate the large degree of variation among models of ‘serious ill-
ness insurance’ in different regions. This new public-private partnership will likely 
continue to positively impact patient access to health care and medicines, increase 
provincial coverage and also boost the growth of the private insurance market.
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best PossibLe HeALtH outcomes At different socioeconomic LeveLs 
of community: tHe better cAre PLAn
Singh A., Khera K.
Manipal College of Pharmaceutical Sciences, Manipal, India
Objectives: Proposal of an ideal model for obtaining the best possible health 
outcomes at different socioeconomic levels of community/population in 
India. cOnclusiOn: Various social inequities viz. race; ethnicity, religions and 
economic status affect operationalization of health decisions as well as health 
outcomes invariably. These all inequities define socioeconomic levels of any com-
munity. Assessing health equity needs comparing health and its social inequities/
determinants within different levels. It is attainable call to standardize the process 
of health care decision making; to obtain best possible health outcomes. Hereby, we 
propose an ideal model; a “Better Care Plan” which would help in opting best possible 
health outcomes at different socioeconomic levels. Foremost, we require to under-
stand the mindset of people on health care needs. We found that one requires clear 
communication; mutual collaboration between clinician, patient and other health 
care professionals; professionally competent and compassionate staff and their 
services; continuity of care and professional excellence required mostly for chronic 
ailment. In next step “better care plan” undertakes evaluation of the impediment 
issues that might rise at various points related to patient, staff and system. Diverse 
quality dimensions proposed by different studies and models would be aimed to 
standardize the process of health care decision making. The six areas of “Better Care 
Plan” involves focus on patient; rationale; efficiency; opportune, safety and potency; 
which would help to obtain optimal health care outcomes at different socioeconomic 
levels. Privatization; where private organizations are committed to serve people with 
government schemes; is one of the important issue which needs improvement. Basic 
implementations such as community services through home medication reviews, 
awareness programs will be helpful with “Better Care Plan”.
infection – clinical outcomes studies
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imPAct of cigArette And ALcoHoL use on Adverse drug reActions of 
HAArt tHerAPy Among Hiv/Aids PAtients
Khan A.H.1, Syed Sulaiman S.A.1, Khan K.1, Soo C.T.2, Akhtar A.1
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tHe coverAge witH cLinicAL evidence-informed decisions (cceds):  
A new HeALtH cAre PAyment modeL in cHinA
He J., Liu G.
Health Economics Association of Guangdong Province, Guangzhou, China
Objectives: The traditional payment methods like fee-for-service and capitation 
were applied to public health in China, the former lead to a problem that health 
insurance cost rising rapidly, while the latter could result in insufficient funds for 
covering the cost of services needed. This study aim to suggest a new payment 
model, based on the coverage with clinical evidence-informed decisions (CCEDs), 
for overcoming the imperfections and making sustained improvement in the med-
ical insurance policy. MethOds: This new health care payment model CCEDs is a 
single, risk-adjusted, prospective (or retrospective) payment model, used as a tool 
to bring a new rationale to payment decisions across inpatients and outpatients 
diagnosed with a specific condition. CCEDs make payment decisions on the basis 
of the following issues: the resources required to provide care as recommended 
according to the clinical practice guidelines; the provider performance on meas-
ures of clinical process, treatment variation, outcomes of care and reimbursement; 
the expert advice in specific health care field. Results: This new model CCEDs 
designed to bring down medical costs and enhance the quality of care, CCEDs 
also come with opportunities to limit both underuse and overuse, eliminate risk 
selection problems, lower administrative cost, enhance transparency of results 
may earning patients trust, increase both patient outcomes and patient satisfac-
tion. Incentives of CCEDs could encourage collaborative teamwork, and promote 
clinical integration between providers across disparate settings. But, meanwhile 
encroachment of the market could undermine the professional discretion in the 
long-term. cOnclusiOn: A new payment model, based on coverage with clini-
cal evidence-informed decisions, might provide new options to get high-quality 
treatment and low medical cost for patients.
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cHALLenges And oPPortunities in tHe mALAysiAn HeALtH cAre system
Mohd Tahir N.A.1, Li S.C.2, Thomas P.3
1University of Newcastle, New South Wales, Australia, 2University of Newcastle, Callaghan, 
Australia, 3Taylor’s University, Selangor, Malaysia
intROductiOn: Malaysia is a multicultural society with a population of over 
28 million and classified as an upper middle-income country by the World Bank. 
Malaysia inherited a health care system at independence from British colonial 
rule and provides universal and low cost access to the health care needs of all 
citizens. Improvements in health indices such as reduction in mortality rate and 
increase in life expectancy using a relatively small amount of GDP (~4%) being 
spent on health services shows that Malaysians have benefited from a well-
developed health care system. chAllenges: Demographic and disease pattern 
transition, increasing cost of health care together with increasing demand towards 
better health outcomes pose challenges in sustaining the system. Historical-based 
health care financing has also created inequity in access and allocative inef-
ficiency. Equity access issues such as uneven human resource distribution and 
limitations in secondary access to consult specialists remain a problem despite 
generally improved access to facilities for rural population. Urbanization how-
ever has created vertical inequity and strains to existing public health facilities. 
The inadequate availability of public health facilities and manpower has led to a 
proliferation of private health facilities. Unethical prescribers’ behaviour, queue 
jumping and dependence on profit-oriented private health care providers further 
complicate the issues. OppORtunities: Restructuring of the financial system by 
introducing national health insurance or co-payment can reduce moral hazards 
associated with the universal low cost system. Strategizing budget allocation in 
building facilities, implementing interventions and preventive programmes based 
on recent transition in health are important measures to be considered. Quality 
use of medicines concept implementation could improve the procurement, supply 
and distribution system as well as skills, awareness and knowledge of prescrib-
ers and patients. Access and efficiency of the health care system could also be 
improved through this concept. Practices and facilities sharing nationally and 
internationally, with neighbouring countries, would also improve access.
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coLLAborAtive APProAcH in Accessing Homogeneous medicAL dAtA in 
grid-bAsed environment (enHAncing diseAses cLAssificAtion)
Khor E.T.
University Sains Malaysia, Penang, Malaysia
Objectives: The proposed initiative presents the collaborative approach in clas-
sification of preliminary characteristics of diseases using sample clinical data that 
allows the integration of parallel processing in homogeneous grid-based environ-
ment. The research focuses on three objectives mainly: 1. To provide collaborative 
classification in homogeneous resources. 2. To conduct parallel processing in extrac-
tion of preliminary characteristics using electronic medical records (EMR) data. 
3. To perform characterization for disease features in grid-based neural network 
classification. MethOds: The study conducted on Globus (Grid) clustering network 
and interconnected with homogeneous resources as test bed. The integration of 
homogeneous sample diseases databases for execution of computational applica-
tion were submitted to the GRAM service to the local scheduling system. The result 
for time and threads computation was computed on the test bed for homogene-
ous resources in grid platform with Feed-Forward Neural Networks. pReliMinARy 
Results: In the training phase, the diversity of clinical data features such as age, 
gender, race/ethnicity were imported as input to the Globus nodes with the aid 
of Globus automated scheduling for diseases’ characteristics classification. The 
coordination of resources aims to address the issue of optimization in distributed 
grid resources. The evaluation of outcome includes response time and co-allocation 
of multiple resources to meet complex clustering of diseases’ characteristics using 
neural networks classification.
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cHronic HePAtitis c PrevALence And its correLAtion witH cd4 
ceLLs And Liver enzymes Among Hiv Positive PAtients: A mALAysiAn 
scenArio
Khan A.H.1, Sulaiman S.A.2, Soo C.T.3, Akhtar A.1, Hamzah D.A.B.A.4, Khan K1
1Universiti Sains Malaysia, Minden, Malaysia, 2Universiti Sains Malaysia, Penang, Malaysia, 
3medical department Penang hospital, penang, Minden, Malaysia, 4Urology Unit, Department of 
Surgery, Health Campus, Universiti Sains Malaysia, Kubang Kerian, 16150, Kelantan, Malaysia, 
Kelantan Malaysia, Malaysia
Objectives: To evaluate the occurrence and clinical outcomes of Hepatitis C (HCV) 
patients co-infected with Human Immunodeficiency Syndrome (HIV) in a tertiary 
care hospital. MethOds: A retrospective study of the patients with clinical histories 
of HIV co-infection with HCV following HAART therapy in Infectious disease Unit at 
Hospital Palau Pinang (HPP), Malaysia from the year 2007 to 2012. The clinical and 
demographic data was collected from patient’s records. In present study we analyzed 
the collected data by using SPSS software (Version 20) to determine the correlation 
of variables and measure their infection rates in a particular population. Results: 
The study involves a total of 708 HIV infected patients with the mean age of 40 ± 
10.17 years together with 541(76.4%) males and 167(23.6%) females. There were 
130(18.4%) patients co-infected with HCV. The assigned population involve in cur-
rent study was Chinese 427(60.3%) followed by Indians 96(13.6%), Malay 151(21.3%) 
and minorities 34 (4.8%). There were three main modes of transmission including 
male heterosexual contact 506(71.5%), homosexual contact 47(6.6%) and intrave-
nous drug users (IVDU) 114(16.1%). The mean CD4 count, ALT and AST levels in 
HBV-HIV co-infected patients were 374 ± 150.65, 64 ± 76.15, 129 ± 61.06 respectively. 
The calculated result shows the significant association of several factors like sex 
(p = < 0.001), IVDU (p = < 0.001) with co-infection of HIV-HCV. The co-morbidities 
observed in the current study were Pulmonary Tuberculosis (23.6%), Pneumocystis 
pneumonia (14.4%), Hyperlipidemia (4.4%), Dyslipidemia (3.2%), Anemia (4.5%), 
Ischemic Heart Disease (2.5%), Diabetes Mellitus (8.2%), Hypertension (6.5%), 
Asthma (1.4%), Oral Candiasis (5.2%), Syphillus (3.1%), Liver Cirrohsis (1.1%), Cerebral 
Toxoplasmosis (2.3%), Virological Failure (1.1%). cOnclusiOns: The incidence rate 
of HCV among HIV individuals were about 18.4% including 76.4% males and 23.6% 
females. There was a significant correlation between HCV among HIV-positive 
patients depending on various variables like gender, age, exposure to risk factors. 
(p< 0.001).
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effectiveness of HAnd Hygiene Promotion in reLAtion to LeveL of 
investment: A systemAtic review
Luangasanatip N., Hongsuwan M., Lubell Y., Cooper B.S.
Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
Objectives: Hand-hygiene amongst health care workers is amongst the most 
effective measures to reduce health care-associated infections, but compliance 
is often poor and little is known about the relative effectiveness of interventions 
to improve it. This study aimed to evaluate the effectiveness of hand-hygiene pro-
motion interventions and to study the association between levels of investment 
in interventions and improved compliance. MethOds: A search strategy was 
developed and electronic databases searched for studies published before March 
2014. Studies failing to meet the Cochrane Effective Practice and Organisation 
of Care Group (EPOC) inclusion criteria were rejected. Where studies had not 
used appropriate analytical methods, we re-analysed primary data. Information 
on resources required for interventions was extracted, and graded into three 
levels. Random effects meta-analysis was performed on studies considered 
sufficiently homogeneous with regard to interventions, participants and outcome 
measures. Results: Of 3,725 studies retrieved, 125 met inclusion criteria; 35 of 
these met EPOC criteria (6 randomised controlled trials (RCTs), 25 interrupted 
time-series (ITS), 2 controlled trials, and 2 controlled before-and-after studies). In 
four RCTs, hand-hygiene compliance was the primary outcome. Meta-analysis of 
these showed the intervention was associated with improved compliance (pooled 
odds ratio [OR], 1.39; 95%CI, 1.15-1.67, I2= 80.00%). Of the 13 ITS studies, 12 showed 
significant stepwise increases in hand-hygiene compliance. All but three of these 
also showed a post-intervention trend for increasing hand-hygiene compliance. 
Grouping studies by the level of investment, 22 were graded as resource-intensive 
while 11 and 2 studies had medium or low levels of investment, respectively. We 
found no evidence of a relationship between the level of investment and effect 
size. cOnclusiOns: Hand hygiene promotion has a positive impact on hand 
hygiene compliance, but evidence that increased investment in hand hygiene 
leads to larger improvements is lacking. Reporting on resources used for interven-
tions was, however, poor.
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burden of vAriceLLA in AsiA-PAcific countries: A systemAtic review 
And criticAL AnALysis
Yang H.K., Huang M.Y.
Merck & Co., Inc, West Point, PA, USA
Objectives: Varicella is a common, vaccine-preventable illness but its impact on 
public health in Asia-Pacific countries has received little attention. This study aimed 
to review the epidemiology and economic burden of varicella in Asia-Pacific coun-
tries. MethOds: A systematic literature review was conducted using PubMed and 
government web sites. Outcomes included epidemiology of varicella (incidence, 
mortality, and complication), vaccination policy and coverage, and varicella-related 
health care resource utilization and costs. Critical analyses of study quality and 
data gaps were performed. Results: Published data were identified from thirteen 
countries including Australia, China, India, Japan, Korea, Malaysia, New Zealand, 
Pakistan, Philippines, Singapore, Sri Lanka, Taiwan, and Thailand. No studies were 
identified for Indonesia and Vietnam. Publicly funded universal childhood vacci-
nation against varicella has been implemented in Australia, Korea, and Taiwan, 
while the remaining countries either recommend vaccination for only high-risk 
1Universiti Sains Malaysia, Minden, Malaysia, 2medical department Penang hospital, penang, 
Minden, Malaysia
Objectives: The aim of the current study is to explore and to observe the impact 
of cigarette smoking and alcohol use on adverse drug reactions occurrence 
of antiretroviral drugs among HIV/AIDS patients. MethOds: Retrospective 
analysis of all patients diagnosed with HIV infection and on HAART therapy 
from Jan 2007 to Dec 2012 was conducted at infections disease department 
of Hospital Pulau Pinang, Malaysia. Patient socio-demographic details along 
with clinical features were recorded and the susceptible ADRs were observed 
during the study period. Data was descriptively analyzed by using statistical 
package for social sciences (SPSS 20). Results: Out of 743 patients that under-
went HAART therapy, 314 (42.2%) patients had experienced adverse drug reac-
tions. Out of total included patients 571 (76.8%) were male and 172 (23.1%) were 
female. Among the patients, 512 (68.9%) were smokers and 340 (45.8%) patients 
were alcohol users. A total number of 425 (57.2%) adverse drug reactions were 
recorded of which 269 (63.2%) were reported among smokers and 162 (38.1%) 
were reported among alcohol users. Univariate analysis indicates a statistical 
significant relationship between the smoker (p-value = 0.009, 95% CI= 1.111 – 
2.079, Odd ratio= 1.520) and alcohol users (p-value= 0.008, 95% CI= 1.106 – 1.994, 
Odd ratio= 1.485) with the occurrence of adverse drug reactions on HAART in 
HIV patients. cOnclusiOns: The study indicates the incidence of adverse drug 
reactions is significant in smokers and alcohol users on HAART therapy. Patient 
counselling on avoiding smoking and alcohol consumption can reduce ADRs in 
patients on HAART therapy.
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Adverse drug reActions of HAArt tHerAPy Among Hiv/Aids PAtients 
treAted At infectious diseAse cLinic
Khan A.H.1, Syed Sulaiman S.A.1, Khan K.1, Aftab R.A.1, Soo C.T.2
1Universiti Sains Malaysia, Minden, Malaysia, 2medical department Penang hospital, penang, 
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Objectives: Current study is aimed to explore and to observe adverse drug reac-
tions occurrence of antiretroviral drugs among HIV/AIDS patients. MethOds: An 
observational retrospective study of all patients diagnosed of HIV infection and 
on HAART therapy from Jan 2007 to Dec 2012 was conducted at infectious disease 
department of Hospital Pulau Pinang, Malaysia. Patient socio-demographic details 
along with clinical features were recorded. The reported ADRs were assessed for 
causality by using Noranjo’s algorithm scale. Data was descriptively analyzed by 
using statistical package for social sciences (SPSS 20). Results: Out of 743 patients 
that underwent HAART therapy, 571 (76.8%) were male and 172 (23.1%) were female 
patients. Overall 314 (42.2%) patients had experienced adverse drug reactions. 
A total number of 425 (57.2%) adverse drug reactions were reported among which 
311 (73.1%) occurred in males and 114 (26.8%) in female patients. Lipodystrophy 
151 (35.5%) was the most common ADR reported; in male 126 (29.6%) and 
25 (5.8%) female patients were recorded. Lipodystrophy was followed by skin 
rashes 80 (18.8%) that included 56 (13.1%) male and 24 (5.7%) female patients. 
Anaemia was reported 74 (17.4%), of which 49 (11.5%) observed in male and 25 
(5.8%) female patients. A statistical significant relationship on Chi-square test 
was observed between the gender and the occurrence of adverse drug reactions 
(p-value = 0.002). However on univariate analysis the relationship between ADRs 
with gender resulted in insignificant value (p-value= 0.267, 95% CI= 0.862 – 1.712, 
Odd ratio= 1.215). cOnclusiOns: The study indicates the incidence of adverse 
drug reactions is higher in male than in female patients. However, a multicenter 
study with a large sample size may provide us with better understanding of this 
relationship.
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imPAct of HePAtitis b on HumAn immunodeficiency virus PAtients in 
mALAysiA: A retrosPective study
Khan A.H.1, Syed Sulaiman S.A.1, Akhtar A.1, Adnan A.S.2, Aftab R.A.1
1Universiti Sains Malaysia, Minden, Malaysia, 2CKD resource centre, Hospital Universiti Sains 
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Objectives: To assess the prevalence and clinical outcomes of Hepatitis B 
(HBV) patients co-infected with Human Immunodeficiency Syndrome (HIV) 
in a tertiary care hospital. MethOds: A retrospective cross-sectional study 
was performed, of HBV positive HIV infected patients following HAART ther-
apy from 2007 to 2012 in Infectious disease Unit, Hospital Palau Pinang (HPP), 
Malaysia. The demographic and clinical data of the patients was collected ret-
rospectively. The collected data was analyzed with SPSS software (Version 20) 
to measure the correlation of variables and their infection rates. Results: A 
total of 664 HIV infected patients including 495 (74.5%) males and 169 (25.5%) 
females with mean age of 40 ± 10.35 years were included in present study. 
Of these, 86 (13%) were co-infected with HBV. The main race involved in cur-
rent study was Chinese 455 (68.5%) followed by Indians 88 (13.3%), Malay 83 
(12.5%) and minorities 38 (5.7%). The route of transmission was mainly male 
heterosexual contact 464 (69.9%) followed by homosexual 47(7.1%) and Intra-
Venous Drug Users (IVDU) 48 (7.2%). The mean CD4 count, ALT and AST lev-
els in HBV-HIV co-infected patients were 385 ± 148.55, 51.48 ± 39.42, 105.581 
± 38.37 respectively. The co-infection is significantly associated with gender 
(p = 0.05), and IVDU (p = 0.01). The co-morbidities seen in the present study 
were Pulmonary Tuberculosis (17.9%), Pneumocystis pneumonia (15.4%), 
Hyperlipidemia (4.1%), Dyslipidemia (4.1%), Anemia (5.1%), Ischemic Heart 
Disease (1.8%), Diabetes Mellitus (8.7%), Hypertension (6.9%), Asthma (1.5%), Oral 
Candiasis (5.6%), Syphillus (4.2%), Liver Cirrohsis (0.6%), Cerebral Toxoplasmosis 
(1.8%), Virological Failure (0.6%). cOnclusiOns: The overall prevalence of HBV 
among HIV patients were about 13% in which 74.5% was males while 25.5 % 
females. Raised levels of liver enzymes and lowered CD4 counts were seen in the 
co-infected patients. There was a significant correlation between co-infection 
with HBV among HIV patients depending on different variables.
